Skip to search formSkip to main contentSkip to account menu

NK 104

Known as: NK-104 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

pitavastatinpitavastatin calcium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Effect of NK-104 on NF-κB activated by TNF-α in hepatocellular carcinoma cells
Background and purpose:A causal relationship between inflammation and cancer has been extensively investigated. Nuclear factor… 
2004
2004
Isolation of Total RNA , Purification of Poly ( A ) RNA , and Northern Blotting
Background—Pitavastatin (NK-104) is a novel inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate… 
2003
2003
新規HMG-CoA還元酵素阻害薬ピタバスタチン (NK-104) の薬物間相互作用 シクロスポリンのピタバスタチン血漿中濃度に及ぼす影響
2003
2003
Pitavastatin (NK-104) Exerts Vasculo-Protective Action by Upregulation of Endothelial Aminopeptidase N (APN/CD13) Expression
2002
2002
A Novel HMG CoA Reductase Inhibitor, NK-104, Inhibits MCP-1-Induced THP-1 Transition from Rolling to Stable Adhesion Under Flow
2001
2001
Studies on metabolic fate of pitavastatin (NK-104), a new inhibitor of HMG-CoA reductase-Is the metabolism of pitavastatin in monkey similar to that in human?
2001
2001
Studies on metabolic fate of pitavastatin (NK-104), a new inhibitor of HMG-CoA reductase-Does glucronidation mediate the lactonization of pitavastatin?
1998
1998
(+)-Monocalcium bis[(3R, 5S, 6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3, 5-dihydroxy-6-heptenoate] (NK104) のイヌを用いた経口投与による12カ月間反復投与毒性試験および2カ月間回復試験
  • 哲雄 渋田靖暁 加藤 正美 滝本
  • 1998
  • Corpus ID: 82225052
1998
1998
Clinical effect of NK-104 (Nisvastatin) on hyperlipidemia -double-blind comparative dose-finding study in three parallel groups-
1996
1996
Novel synthetic strategy for HMG-CoA reductase inhibitors
Abstract